Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
5.75
-0.16 (-2.71%)
At close: Dec 5, 2025, 4:00 PM EST
5.74
-0.01 (-0.17%)
After-hours: Dec 5, 2025, 6:15 PM EST

Karyopharm Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
9885993854861,139
Upgrade
Market Cap Growth
-1.56%-13.86%-74.26%-20.76%-57.36%-5.35%
Upgrade
Enterprise Value
3222202015495951,079
Upgrade
Last Close Price
5.7510.1412.9751.0096.45232.20
Upgrade
PS Ratio
0.340.590.682.452.3210.54
Upgrade
PB Ratio
--0.46-0.73-23.11-6.1022.54
Upgrade
P/TBV Ratio
-----22.54
Upgrade
EV/Sales Ratio
2.261.511.383.502.849.99
Upgrade
Debt / Equity Ratio
-1.00-1.44-2.27-18.72-3.944.04
Upgrade
Asset Turnover
1.000.720.490.470.680.36
Upgrade
Inventory Turnover
-1.541.361.251.011.81
Upgrade
Quick Ratio
0.891.513.165.053.434.35
Upgrade
Current Ratio
1.031.703.375.313.744.59
Upgrade
Return on Equity (ROE)
------391.29%
Upgrade
Return on Assets (ROA)
-45.56%-36.88%-27.05%-26.79%-19.86%-35.33%
Upgrade
Return on Capital (ROIC)
-119.68%-58.48%-34.57%-33.60%-25.14%-42.72%
Upgrade
Return on Capital Employed (ROCE)
-1147.60%-165.50%-75.80%-48.70%-42.40%-68.00%
Upgrade
Earnings Yield
-127.11%-89.55%-144.44%-42.94%-25.55%-17.23%
Upgrade
FCF Yield
-91.08%-149.55%-93.59%-38.88%-22.09%-14.08%
Upgrade
Buyback Yield / Dilution
-7.52%-11.02%-39.51%-8.85%-4.41%-16.28%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.